CIRCULATING IMMUNE COMPLEXES IN DIABETESDI MARIO U; IAVICOLI M; ANDREANI D et al.1980; DIABETOLOGIA; DEU; DA. 1980; VOL. 19; NO 2; PP. 89-92; BIBL. 50 REF.Article

HYPOGLYCAEMIC SYNDROMES AND ANTIBODIES TO PANCREATIC ISLET CELLS.DI MARIO U; TAMBURRANO G; IAVICOLI M et al.1977; CLIN. EXPER. IMMUNOL.; G.B.; DA. 1977; VOL. 29; NO 3; PP. 523-524; BIBL. 13 REF.Article

GLUCAGON AND GROWTH HORMONE SECRETION IN INSULIN-TREATED DIABETICS: EFFECTS OF ADDED SULFONYLUREAS.FALLUCCA F; IAVICOLI M; MENZINGER G et al.1978; METABOLISM; U.S.A.; DA. 1978; VOL. 27; NO 1; PP. 5-11; BIBL. 23 REF.Article

ASPECTS OF HUMORAL IMMUNITY IN A PROSPECTIVE STUDY OF TYPE I (INSULIN-DEPENDENT) DIABETIC SUBJECTS TREATED WITH INSULINS OF DIFFERENT PURITYIAVICOLI M; VENTRIGLIA L; DIMARIO U et al.1983; DIABETOLOGIA; ISSN 0012-186X; DEU; DA. 1983; VOL. 24; NO 1; PP. 26-29; BIBL. 21 REF.Article

COMPARATIVE TRIALS WITH MONOCOMPONENT (MC) AND MONOSPECIES (MS) PORK INSULINS IN THE TREATMENT OF DIABETES MELLITUS. INFLUENCE ON ANTIBODY LEVELS, ON INSULIN REQUIREMENT AND ON SOME COMPLICATIONS = ESSAIS COMPARES AVEC LES INSULINES DE PORC MONOCOMPOSE (MC) ET MONOSPECIFIQUE (MS) DANS LE TRAITEMENT DU DIABETE SUCRE. INFLUENCE SUR LES TAUX DES ANTICORPS, SUR LE BESOIN EN INSULINE ET SUR QUELQUES COMPLICATIONSANDREANI D; IAVICOLI M; TAMBURRANO G et al.1974; HORMONE METABOL. RES.; GERM.; DA. 1974; VOL. 6; NO 6; PP. 447-454; BIBL. 26 REF.Article

CIRCULATING IMMUNE COMPLEXES IN DIABETICS WITH SEVERE MICROANGIOPATHY: EVALUATION BY TWO DIFFERENT METHODANDREANI D; DI MARIO U; GALFO C et al.1982; ACTA ENDOCRINOL. (KBH.); ISSN 0001-5598; DNK; DA. 1982; VOL. 99; NO 2; PP. 239-244; BIBL. 28 REF.Article

IMPAIRED PHAGOCYTIC FUNCTION AND INCREASED IMMUNE COMPLEXES IN DIABETICS WITH SEVERE MICROANGIOPATHYIAVICOLI M; DI MARIO U; POZZILLI P et al.1982; DIABETES (N.Y.); ISSN 0012-1797; USA; DA. 1982; VOL. 31; NO 1; PP. 7-11; BIBL. 20 REF.Article

Immunologic factors in the etiopathogenesis of type I diabetesDI MARIO, U; IAVICOLI, M; ANDREANI, D et al.Frontiers in diabetes. 1982, Vol 4, pp 26-35, issn 0251-5342Article

Prevention of early-morning hyperglycemia in IDDM patients with long-acting zinc insulinPARILLO, M; MURA, A; IOVINE, C et al.Diabetes care. 1992, Vol 15, Num 2, pp 173-177, issn 0149-5992Article

Cardiac performance and mass in adults with hypopituitarism : effects of one year of growth hormone treatmentVALCAVI, R; GADDI, O; ZINI, M et al.The Journal of clinical endocrinology and metabolism. 1995, Vol 80, Num 2, pp 659-666, issn 0021-972XArticle

Lymphocyte subsets and immune complexes in long standing diabetic patients: relation with the presence of microangiopathyANDREANI, D; DI MARIO, U; ZUCCARINI, O et al.Immunology letters. 1984, Vol 8, pp 17-21, issn 0165-2478Article

Humoral immunity in diabetic pregnancy: interrelationships with maternal/neonatal complications and maternal metabolic controlFALLUCCA, F; DI MARIO, U; GARGIULO, P et al.Diabète et métabolisme (Paris). 1985, Vol 11, Num 6, pp 386-395, issn 0338-1684Article

Partial recovery of insulin secretion and action after combined insulin-sulfonylurea treatment in type 2 (non-insulin-dependent) diabetic patients with secondary failure to oral agentsDEL PRATO, S; VIGILI DE KREUTZENBERG, S; RICCIO, A et al.Diabetologia (Berlin). 1990, Vol 33, Num 11, pp 688-695, issn 0012-186XArticle

Blood glucose control and insulin secretion improved with combined therapy in type 2 diabetic patients with secondary failure to oral hypoglycaemic agentsIAVICOLI, M; CUCINOTTA, D; DE MATTIA, G et al.Diabetic medicine. 1988, Vol 5, Num 9, pp 849-855, issn 0742-3071Article

Insulin and sulfonylurea therapy in NIDDM patients : Are the effects on lipoprotein metabolism different even with similar blood glucose control?ROMANO, G; PATTI, L; INNELLI, F et al.Diabetes (New York, NY). 1997, Vol 46, Num 10, pp 1601-1606, issn 0012-1797Article